81.2 +2.0 (+2.46%) Sell

Looking to invest in KESORAMIND? Consider it, because it managed to outperform the broader market

13 min read

KESORAM INDUSTRIES LTD outperformed today. It surged by +2.46% to close at 81.2. It's recent 5 day performance has been -1.0%, -0.99%, -1.46%, -1.97% and +3.98%.

[Themes containing KESORAMIND]

KESORAMIND showed a strong bullish trend over the last 3 months. During this period KESORAMIND surged by +42.33% and saw a maximum drawdown of -19.79%. There was a long signal during this period which returned +39.56%.


KESORAMIND has been underperforming the NIFTY-50 index in recent time. It showed significant underperformance (compared to the NIFTY-50 index) from 4 Oct, 2016 to 25 Sep, 2018. Over the last 3 years and 1 month, KESORAMIND underperformed the NIFTY-50 index on 55% days.

KESORAMIND was profitable on 50% days in the last three months. During this time, it delivered on average +0.65% per day. It delivered it's best daily return of +19.95%, during this period, on Wednesday, 21 Nov, 2018. The longest stort-term trend during this period was 7 profitable days, which started on 29 Oct, 2018 and went on till 6 Nov, 2018. This bullish trend returned +10.88% to investors.

During the last year KESORAMIND had 3 profitable months and 9 loss making months. KESORAMIND returned profits in fewer months than NIFTY-50 index. KESORAMIND significantly outperformed NIFTY-50 index in Nov 2018, when it returned +45.51% compared to +6.56% returned by NIFTY-50 index during it's best month in the last one year - Jul 2018. KESORAMIND had a longer winning streak of losing months than NIFTY-50 index. It went down in 5 straight months (from Feb 2018 to Jun 2018) during which period it delivered -59.68%. It is interesting to note that both KESORAMIND and NIFTY-50 index significantly outperform during months when quarterly/annual results are announced.

Making money from enforcing patents is no more wrong than investing in preferred stock.
-- Nathan Myhrvold

KESORAMIND is currently seeing overall fall in volatility. In comparison, the NIFTY-50 index is seeing decrease in volatility. During the last three months, there was a significant fall in KESORAMIND's volatility from 21 Nov, 2018 to 15 Jan, 2019. While there was a significant fall in the NIFTY-50 index's volatility from 31 Oct, 2018 to 5 Dec, 2018.

Advanced/professional short-term investors should note that KESORAMIND has significant negative skewness in it's return distribution. This indicates that KESORAMIND is very risky for short-term investment and can significantly underperform for long durations.

NIFTY-50 index has more chance of extreme outcomes than KESORAMIND. Therefore, NIFTY-50 must receive a lower allocation than KESORAMIND in your portfolio. NIFTY-50 index usually has shorter drawdown period than KESORAMIND.

Based on your interest in KESORAMIND you may find it interesting to know that TORNTPHARM and BAJAJFINSV are both large caps that have shown remarkable performance and deserve to be on every investors' watchlist.

Want to improve your Portfolio's performance?

Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
If you liked what you read here ...

... we have a small favour to ask. Help us bring the power of algorithmic trading strategies to individual investors.

All content in this article was automatically generated by algorithms. This ensures that there are no human biases in the analysis provided. This approach to investing is not new and has been around for more than three decades. Yet, it has been available to only the most affluent or elite investors leaving individual investors to trade on emotions (such as fear and greed), intuition and poor analysis from third-parties. We want to change this.

We want to empower investors with all the tools and analysis required by them to make a rational investment decision.

If you found Spotalpha useful, consider making a contribution. For as little as $5 you can support our efforts and it takes less than a minute. Thank you. Contribute
Share with friends   WhatsApp   Facebook   Twitter